Freya Pharma Solutions is an Amsterdam, The Netherlands, based late clinical stage pharmaceutical company focusing on the development of effective pharmaceutical therapies for female sexual interest/arousal disorder (FSIAD). Freya will build further upon the previous fifteen years of research with two pharmaceutical compounds Lybrido and Lybridos. Bringing a therapy for this recognized unmet medical need to the market and available to patients.